Thomas Dahl Nissen
Aalborg University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Thomas Dahl Nissen.
Neurogastroenterology and Motility | 2008
Christina Brock; Thomas Dahl Nissen; F. H. Gravesen; Jens Brøndum Frøkjær; H. Omar; Jeremy D. Gale; Henrik Gregersen; O. Svendsen; Asbjørn Mohr Drewes
Abstract Evaluation of rectal and rectosigmoid sensation is important in basic, clinical and pharmacological studies. New methods to evoke and assess multimodal (electrical, thermal and mechanical) experimental pain of the upper gut activate distinct pathways and mimics clinical pain. The aims of the current study were to characterize the sensory response and reproducibility to multimodal stimulation of rectum and the rectosigmoid. A multimodal rectal probe was developed. Mucosal electrostimulation was delivered at the recto‐sigmoid junction. In Rectum, impedance planimetry was used for measurement of cross‐sectional area (CSA) during distension. Circulation of water within the bag at either 4 or 60 °C was applied for thermal stimulation. The method was tested in 12 healthy volunteers (six men mean age 32 years) on two subsequent days. Mechanical and sensory responses and referred pain areas were assessed. Stimulation with electrical, thermal and mechanical modalities resulted in different sensory perceptions. The relationship between stimulus intensity and sensory response was linear for all modalities. Sensory response to different modalities did not differ between investigation days (all P‐values > 0.1). Approximately 75% of subjects felt referred pain in distinct skin locations. Between‐days reproducibility was good for all modalities [intra‐class correlation (ICC) ≥0.6]. At sensory threshold, CSA showed best reproducibility (ICC ≥ 0.9). At pain detection threshold stretch ratio, CSA and electrostimulation showed best reproducibility (ICC = 1.0; 0.9; 0.9). The present model was easily implemented, robust and showed good reproducibility. It can be used to study pathophysiology or pharmacological interventions in healthy controls and in patients with diseases involving the distal hindgut.
Neurogastroenterology and Motility | 2012
Leif Hultin; Thomas Dahl Nissen; D. Kakol-Palm; Erik Lindström
Background Quantification of the visceromotor response induced by colorectal distension (CRD) in rodents is commonly used for preclinical studies of visceral pain. The model is well established but does not fully assess the central response to stimulation. The aim of this study was to establish a novel model assessing cerebral evoked potentials (CEPs) in response to CRD in awake rats.
World Journal of Gastroenterology | 2013
Jingbo Zhao; Donghua Liao; Thomas Dahl Nissen
Chronic pancreatitis affects many individuals around the world, and the study of the underlying mechanisms leading to better treatment possibilities are important tasks. Therefore, animal models are needed to illustrate the basic study of pancreatitis. Recently, animal models of acute and chronic pancreatitis have been thoroughly reviewed, but few reviews address the important aspect on the translation of animal studies to human studies. It is well known that pancreatitis is associated with epigastric pain, but the understanding regarding to mechanisms and appropriate treatment of this pain is still unclear. Using animal models to study pancreatitis associated visceral pain is difficult, however, these types of models are a unique way to reveal the mechanisms behind pancreatitis associated visceral pain. In this review, the animal models of acute, chronic and un-common pancreatitis are briefly outlined and animal models related to pancreatitis associated visceral pain are also addressed.
Neurogastroenterology and Motility | 2014
S. Haas; Christina Brock; Klaus Krogh; Mikkel Gram; Thomas Dahl Nissen; Lilli Lundby; Søren Laurberg; Asbjørn Mohr Drewes
Neurophysiological evaluation of anorectal sensory function is hampered by a paucity of methods. Rapid balloon distension (RBD) has been introduced to describe the cerebral response to rectal distension, but it has not successfully been applied to the anal canal.
American Journal of Physiology-gastrointestinal and Liver Physiology | 2013
Thomas Dahl Nissen; Christina Brock; Carina Graversen; Steven J. Coen; Leif Hultin; Qasim Aziz; Jens Lykkesfeldt; Asbjørn Mohr Drewes
Inconsistencies between species has stunted the progress of developing new analgesics. To increase the success of translating results between species, improved comparable models are required. Twelve rats received rectal balloon distensions on 2 different days separated by 24.3 (SD 24.6) days. Rectal balloon distensions were also performed in 18 humans (mean age: 34 yr; range: 21-56 yr; 12 men) on two separate occasions, separated by 9.3 (SD 5.5) days. In rats, cerebral evoked potentials (CEPs) were recorded by use of implanted skull-electrodes to distension pressure of 80 mmHg. In humans surface electrodes and individualized pressure, corresponding to pain detection threshold, were used. Comparison of morphology was assessed by wavelet analysis. Within- and between-day reproducibility was assessed in terms of latencies, amplitudes, and frequency content. In rats CEPs showed triphasic morphology. No differences in latencies, amplitudes, and power distribution were seen within or between days (all P ≥ 0.5). Peak-to-peak amplitude between the first positive and negative potential were the most reproducible characteristic within and between days (evaluated by intraclass correlation coefficients, ICC) (ICC = 0.99 and ICC = 9.98, respectively). In humans CEPs showed a triphasic morphology. No differences in latencies, amplitudes, or power distribution were seen within or between days (all P ≥ 0.2). Latency to the second negative potential (ICC = 0.98) and the second positive potential (ICC = 0.95) was the most reproducible characteristic within and between days. A unique and reliable translational platform was established assessing visceral sensitivity in rats and humans, which may improve the translational process of developing new drugs targeting visceral pain.
European Journal of Pain | 2014
Matias Nilsson; A Piasco; Thomas Dahl Nissen; Carina Graversen; Parisa Gazerani; M-F Lucas; Albert Dahan; Asbjørn Mohr Drewes; Christina Brock
Offset analgesia (OA) is a pain‐inhibiting mechanism, defined as a disproportionately large decrease in pain perception in response to a discrete decrease in noxious stimulus intensity. Hence, the aims were (1) to investigate whether psychophysics and electroencephalography (EEG) can be assessed simultaneously during OA and (2) to assess whether OA is reproducible within the same day as well as between different days.
Neurogastroenterology and Motility | 2015
Dina Lelic; Thomas Dahl Nissen; Christina Brock; Qasim Aziz; Asbjørn Mohr Drewes
The processing of discomfort and pain in the central nervous system is normally studied with experimental methods, but it is mandatory that they are reliable over time to ensure that any interventions will result in valid results. We investigated reliability of rapid balloon distension in the rectum to elicit cortical evoked potentials (CEPs) to study the reliability of central processing of visceral sensation and discomfort/pain.
Scandinavian Journal of Pain | 2018
Thomas Dahl Nissen; Carsten Dahl Mørch; Lars Arendt-Nielsen; Asbjørn Mohr Drewes; Anne Estrup Olesen
Abstract Background and aims Offset analgesia (OA) is a pain modulating mechanism described as a disproportionately large decrease in pain intensity evoked by a minor decrease in stimulus intensity. Precise mechanisms of OA are still not elucidated and studies are needed to evaluate factors modulating OA. The aim of this study was to investigate OA before and during tonic cold pain (thought to induce descending inhibition), in a group of healthy volunteers. Methods A randomized, crossover study was performed in 17 healthy participants (8 males and 9 females). The OA paradigm lasted 35 s and was induced by the traditional method using thermal stimulation applied to the forearm. A constant control heat stimulus (CTL) paradigm was used as control to assess adaptation. Pain intensity was assessed continuously. For induction of tonic cold pain, the participants immersed their hand into 2°C water for 2 min. After 1 min and 25 s, the heat stimulation (OA or CTL paradigm) was repeated to assess the modulatory effect of the cold pressor test. Results It was possible to induce OA both before and during the cold pressor test. Tonic cold pain modulated the peak pain reported during both the OA (p=0.015) and CTL paradigms (p=0.001) reflecting endogenous pain modulation. However, the magnitude of OA was not modulated by tonic cold pain (p>0.05). Conclusions The offset analgesia magnitude was not modulated by simultaneously tonic cold pain, thought to reflect another endogenous pain modulation mechanism. Implications Neither offset analgesia magnitude nor adaptation were modulated by cold pressor induced endogenous analgesia. This could be explained by the fact, that offset analgesia was already at maximum in healthy participants. Hence, offset analgesia may not be a suitable assessment tool to investigate modulation induced by experimental methods or pharmacology in healthy participants.
Neuropharmacology | 2018
Thomas Dahl Nissen; Christina Brock; Jens Lykkesfeldt; Erik Lindström; Leif Hultin
Background: Cerebral evoked potentials (CEP) induced by colorectal distension (CRD) in conscious rats provides a novel method in studies of visceral sensitivity. The aim of this study was to explore the pharmacological effect on CEP of compounds known to reduce the visceromotor response to CRD. Methods: Epidural electrodes were chronically implanted in eight female Sprague‐Dawley rats. Evoked potentials were elicited by colorectal rapid balloon distensions (100 ms, 80 mmHg) and the effect of WIN55 (cannabinoid CB receptor agonist), clonidine (adrenergic &agr;2 receptor agonist), MPEP (mGluR5 receptor antagonist), pregabalin (ligand of &agr;2&dgr; subunits in voltage‐gated calcium channels) and baclofen (GABA‐B receptor agonist) on amplitudes and latency of CEP were determined. Results: WIN55 (0.1 &mgr;mol kg−1), clonidine (0.05 &mgr;mol kg−1), MPEP (10 &mgr;mol kg−1) and pregabalin (200 &mgr;mol kg−1) caused a significant, p < 0.05, reduction of the N2 to P2 peak‐to‐peak amplitude by 23 ± 8%, 25 ± 8%, 39 ± 5%, and 47 ± 6% respectively. Baclofen (9 &mgr;mol kg−1) induced a prolongation of the N2 peak latency of 18 ± 4% but had no significant effect on the amplitudes. Conclusion: The obtained results suggest that MPEP, WIN55, clonidine, and pregabalin reduce visceral nociceptive input to the brain, whereas the lack of effect of baclofen on CRD evoked CEP amplitudes suggest that the effect on VMR is not due to a direct analgesic effect. Brain responses to colorectal distension provide a useful tool to evaluate pharmacological effects in rats and may serve as a valuable preclinical model for understanding pharmacological mechanisms related to visceral sensitivity. HighlightsCRD evoked potentials in rats provides a novel method to assess pharmacological effects on supraspinal response to visceral stimulation.MPEP, WIN55, clonidine, and pregabalin reduce visceral nociceptive input to the brain.Baclofen had no significant effect on the amplitudes of the CRD evoked potentials.The results suggest that the effect of baclofen on CRD‐induced VMR is through a different mechanism than MPEP, WIN55, clonidine, and pregabalin.Brain responses to colorectal distension in rats provide a useful tool to evaluate effects of visceral analgesic drugs.
Basic & Clinical Pharmacology & Toxicology | 2018
Anne Estrup Olesen; Thomas Dahl Nissen; Matias Nilsson; Dina Lelic; Christina Brock; Lona Louring Christrup; Asbjørn Mohr Drewes
Offset analgesia (OA) is a pain‐modulating mechanism described as a disproportionately large decrease in pain intensity evoked by a discrete decrease in stimulus temperature. The role of the opioidergic, serotonergic and noradrenergic systems on OA remains unclear. The aim of this study was to evaluate whether OA is modulated by an opioid (oxycodone) and a serotonin and noradrenaline reuptake inhibitor (venlafaxine) in terms of psychophysical assessments. In this randomized, double‐blinded, placebo‐controlled cross‐over study, 20 healthy male participants (mean age: 24.6 ± 2.5 years) received 10 mg oxycodone, 37.5 mg venlafaxine or placebo twice daily for 5 days in three periods. OA was induced by noxious thermal stimulation on the forearm at baseline and last day of treatment. A control session of constant stimulus intensity was included for comparison. OA magnitude was unaffected by oxycodone and venlafaxine (p = 0.20 and p = 0.90, respectively). Oxycodone affected the control paradigm where a decreased rating of pain intensity was observed compared to placebo (p = 0.001). OA could not be modulated by oxycodone or venlafaxine and may be a robust phenomenon in healthy volunteers and not suitable for exploring pharmacological mechanisms of analgesia in human beings.